Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B

NCT07345624 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B Virus Infection
Children
Chronic Hepatitis B

Interventions

DRUG: Entecavir
DRUG: Entecavir + Pegylated interferon α-2b

Sponsor

Qing-Lei Zeng

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]